OncoLens
AI that connects cancer patients to right care
Atlanta, Georgia, US
A precision oncology solutions company.
How We Help
Problem Statement
Fragmented cancer treatment planning due to disparate data sets and lack of collaboration between oncology care teams and stakeholders.
Core Technology
AI/NLP
Key Differentiators
Unifies disparate data sets, oncology care teams, and stakeholders on a singular platform; Simplifies tumor board management; Facilitates survivorship care planning; Automates accreditation and quality reporting; Uses proprietary AI/NLP to search structured and unstructured data within EMR systems
Clinical Focus
Oncology
Company Info
- Business Model
- Hybrid
- Total Funding
- 7,250,000
- Website
- www.oncolens.com
Categories
Disease Areas
Technologies
Clinical & IP
Clinical Validation
Used by 225+ cancer centers and 45,000+ physicians; 70% increase in biomarker testing; 650 hours saved per cohort analysis; AI achieves 85-90% accuracy in patient identification; proven at academic and community centers nationwide.
MedStartr Index Score
?What do you think of OncoLens?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.